Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).

Biotechnology

Tectonic Therapeutic

Alise Reicin

Daniel Lochner

Ashley Smith

Hitesh Soni, Ph.D., MBA

Arthur MARIVIN, PhD

Yao Fan

Rohit Anand

John Diener

Anthony (Tony) Muslin

Peter McNamara

Christian Cortis

Marc Schwabish

Anthony Muslin

Research and Development

Development and Program Management

Leadership Team

Finance Team

Teams at Tectonic Therapeutic

Research and Development

Development and Program Management

Leadership Team

Finance Team